3 ms·
Only problem, I suspect, is it's super expensive and hard to produce in the large amounts required. So not as much of a game changer as we'd like. Still should
by satya71 6y ago
Only problem, I suspect, is it's super expensive and hard to produce in the large amounts required. So not as much of a game changer as we'd like. Still should save a few lives.
- war1025 6y agoTrump released a statement a few hours ago that they have hundreds of thousands of doses available and he's going to push to make it free to patients. Obviously, it's still unclear how the politics of all of it play out, but seems more promising than most things we've seen so far.
- ethbr0 6y ago> it's super expensive and hard to produce in the large amounts required It's hard, but less hard than some things. And we've been working on them for the last ~35 years. Here's a primer if you're curious: https://blogs.sciencemag.org/pipeline/archives/2020/04/27/monoclonal-antibodies-for-the-coronavirus https://blogs.sciencemag.org/pipeline/archives/2020/04/27/mo...
- gameswithgo 6y agoI am lucky enough to have solid insurance provided by work and I had to fight hard to get a monoclonal antibody covered. One that was actually approved by the FDA. The cost if you can't get insurance to cover it is ~$3,000 per dose.
- ethbr0 6y agoThe price, as with all things in American medicine, is what they think the market will bear. They're not trivial to make, but it's an understood process. That said, there's been a lot of research and money to get us to where we are today. So how to value that? I've no idea.